New York, NY · Founded 2019 · Privately Held (backing)
Developer of novel chemical entities designed to transform the treatment of psychiatric disorders through rapid-acting and durable therapies. Gilgamesh Pharma is based in New York, NY and was founded in 2019. Its last reported valuation was $189 million in May 2022. It has raised $136 million across 3 recorded rounds; the latest was a $2.3 million seed round in Mar 2026.
Last reported valuation
$188.5M
Oct 2026
Priced at
—
Total raised
$135.8M
Last round
Seed Round
Mar 2026
No prints on record
No secondary trades in Gilgamesh Pharma shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Gilgamesh Pharma with a free account
·The complete investor list: 24 names
·Watch Gilgamesh Pharma: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Gilgamesh Pharma stock.
